Pharming Group
PHAR
13 hedge funds and large institutions have $1.43M invested in Pharming Group in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
18% more funds holding
Funds holding: 11 → 13 (+2)
0.08% less ownership
Funds ownership: 0.2% → 0.12% (-0.08%)
42% less capital invested
Capital invested by funds: $2.48M → $1.43M (-$1.05M)
83% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$68.8K |
| 2 |
Morgan Stanley
New York
|
+$64.2K |
| 3 |
LFG
Larson Financial Group
St Louis,
Missouri
|
+$5.82K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
+$2.17K |
| 5 |
SHIM
Stone House Investment Management
Tunkhannock,
Pennsylvania
|
+$1.34K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NA
NewEdge Advisors
New Orleans,
Louisiana
|
-$453K |
| 2 |
Millennium Management
New York
|
-$360K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$127K |
| 4 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
-$98.3K |
| 5 |
SP
SmartHarvest Portfolios
Poulsbo,
Washington
|
-$32K |
PHAR Hedge Fund Activity: Q1 2026 in Review
13 of the 8,197 institutional investors tracked by Wall St. Rank reported a position in Pharming Group (PHAR) for Q1 2026, worth a combined $1.43M — down 42% from $2.48M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new PHAR positions and 3 closed out — a net gain of 2 holders — while 1 added to existing stakes and 6 trimmed.
The largest buyer was Knoll Capital Management, opening a new position worth an estimated $68.8K. The largest seller was NewEdge Advisors, cutting an estimated $453K.
- 13 institutional investors held Pharming Group (PHAR) as of Q1 2026, up from 11 in Q4 2025.
- Funds reported $1.43M of Pharming Group stock for Q1 2026, down 42% quarter-over-quarter.
- 5 funds opened new Pharming Group positions in Q1 2026 and 3 closed out, a net change of +2 holders.
- The largest Pharming Group buyer in Q1 2026 was Knoll Capital Management, an estimated $68.8K added.
- The largest Pharming Group seller in Q1 2026 was NewEdge Advisors, an estimated $453K sold.
Based on aggregated 13F filings for Q1 2026.